Efficacy and Safety of Itopride vs Placebo in Heartburn
NCT00382577 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 48
Last updated 2017-02-09
Summary
The purpose of this study is to evaluate the effects of itopride in patients with heartburn.
Conditions
- Heartburn
Interventions
- DRUG
-
Itopride
- DRUG
Sponsors & Collaborators
-
Forest Laboratories
lead INDUSTRY
Principal Investigators
-
Philip, Jr. B. Miner, M.D. · The Oklahoma Foundation for Digestive Research
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-10-31
- Completion
- 2006-12-31
Countries
- United States
Study Locations
More Related Trials
-
Placebo Controlled Phase IV Study to Compare the Efficacy and Safety of a Single Dose of Oral Talcid, a Single Dose of Oral Famotidine and a Single Dose of Placebo in Patients With Acute Heartburn Episodes
NCT01928888 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of Controlled Release Arbaclofen Placarbil (XP19986) in Patients With Gastroesophageal Reflux Disease
NCT00838396 ·Status: COMPLETED ·Phase: PHASE2
-
Symptom Improvements in Gastroesophageal Reflux Disease (GERD) Patients
NCT00394472 ·Status: COMPLETED ·Phase: PHASE2
-
E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers
NCT00236197 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May Experience
NCT01043185 ·Status: COMPLETED ·Phase: PHASE2
-
Esophageal Hypersensitivity Study in Patients With Gastroesophageal Reflux Disease (GERD)
NCT01019928 ·Status: COMPLETED ·Phase: PHASE2
-
Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis
NCT00770913 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Do Acid Sensing Ion Channels Contribute to Heartburn?
NCT01095133 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia.
NCT00171457 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of IQP-LH-101 in Postprandial Heartburn
NCT01718639 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD)
NCT00978016 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Investigate the Pharmacodynamic Effect of a Single Dose of AZD2516 in Healthy Male Subjects
NCT01154634 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn.
NCT00171470 ·Status: COMPLETED ·Phase: PHASE3
-
E3810-A001-313: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers
NCT00236184 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare PK, PD and Safety of CKD-382 in Healthy Subjects
NCT04703374 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Investigate the Effect of ONO-8539 on Acid-Induced Oesophageal Hypersensitivity in Healthy Volunteers
NCT01705275 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of AFQ056 and Baclofen on Meal-Induced Gastroesophageal Reflux
NCT00414856 ·Status: COMPLETED ·Phase: PHASE1
-
14473 - D9126C00001 Proof of Principle Study - Effect of AZD2066 on Transient Lower Esophageal Sphincter Relaxations
NCT00813306 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms
NCT00703534 ·Status: COMPLETED ·Phase: PHASE2
-
An Explorative Trial to Evaluate the Pharmacodynamic Effect of SPD557 on Reflux Parameters in Refractory GERD Patients
NCT01370863 ·Status: TERMINATED ·Phase: PHASE2
-
TLESR-impedance Study in Patients
NCT00743444 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare PK, PD and Safety of the AD-213-B and AD-2132
NCT04755985 ·Status: COMPLETED ·Phase: PHASE1
-
Physiology of GERD and Treatment Response
NCT04292470 ·Status: COMPLETED ·Phase: NA
-
Proof of Concept Study Efficacy of an Antacid/Lansoprazole Combination for Relief of Heartburn
NCT01037452 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat Heartburn
NCT00251745 ·Status: COMPLETED ·Phase: PHASE3